Immunome (IMNM)
NASDAQ:IMNM
US Market
Advertisement

Immunome (IMNM) Revenue

Compare
349 Followers

Immunome Revenue

Immunome had a revenue of 0.00 in the quarter ending Sep 30, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 9.68M, Increased -23.12%. In the fiscal year ending Dec 31, 2024, Immunome had annual revenue of 9.04M with -35.50% growth.
Revenue (ttm)
9.68M
Revenue Growth
-4.44%
P/S Ratio
173.87
Revenue/Employee
$69,015
Employees
131
Market Cap
$1.57B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
9.04M-4.98M+64.50%
Dec 31, 2023
14.02M-1,401,800,000.00%
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis